Our Research Pipeline

Our research lies at the intersection of innovation, science, and collaboration. We are proud to present our groundbreaking research line, made possible thanks to the generous funding from government bodies in Spain and the European Union. Our mission is to pioneer genetic and epigenetic solutions for sepsis, adolescent idiopathic scoliosis (AIS), and the integration of artificial intelligence tools and biomarkers for the management of complex conditions. This initiative represents a significant leap forward in improving healthcare outcomes. Together, we are shaping the future of healthcare.

Cooperation Project Valencian Innovation Agency

SAMUEL Project : Augmented artificial vision System for the molecUlar and morphologic charactErization of skin Lesion cancErs Artificial intelligence (AI) tool that integrates digitized histological images, epigenetic information, and clinical data to support diagnosis by pathology specialists, with a primary focus on cancer diagnosis. Start: June 2021 End: September 2023

RED.es

Development of a diagnostic technology based on computational image analysis with integration of epigenetic biomarkers for precision medicine in idiopathic scoliosis ( ScoliVIEW ) Start: 2022 End: 2024

Seal of Excellence-CDTI

(EIC Accelerator)

IVD tool HISTSHOCK: Development of an improved diagnostic test for patients with sepsis and septic shock based on proteomic analysis of biomarkers Start: 2023 End: 2025

PUBLIC-PRIVATE COLLABORATION PROJECTS (PPC)

Identification and validation of biomarkers using omics and Artificial Intelligence for the early diagnosis and improved clinical management of sepsis Start: 2022 End: 2025 Project CPP2021-008643, funded by:

Discover our latest tools

We present our latest products, where we have translated pioneering science into applied IVD tools.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.